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Cirurgia de troca valvar em gestante
Heart valve replacement during pregnancy
Abstract
We describe a woman with gestational age of 20 weeks,
who was submitted to a complex procedure. She underwent
replacement of the biological mitral and aortic valve, both
by biological prosthesis, valvuloplasty of the tricuspid valve,
as well as thrombectomy of the left atrium. Extracorporeal
circulation (ECC) was used during 105 minutes. The patient
was discharged from hospital in good health conditions and
the newborn remained in the Neonatal Intensive Care Unit
(NICU) in a stable state. This is a complex procedure with a
high maternal and fetal mortality. Therefore, this is an
important case regarding valve abnormalities treatment
during pregnancy.
Descriptors: Cardiac surgical procedures. Pregnancy.
Heart valve prosthesis. Mitral valve, surgery. Aortic valve,
surgery.
Resumo
Trata-se de uma gestante de 20 semanas submetida à
retroca de prótese de valva atrioventricular esquerda e troca
da valva da aorta, ambas por prótese biológica, valvuloplastia
de tricúspide e trombectomia de átrio esquerdo. O tempo de
circulação extracorpórea foi de 105 minutos. A paciente
recebeu alta do hospital em boas condições gerais e o recém-
nascido permanece estável em Unidade de Terapia Intensiva.
Por ser um procedimento de considerável complexidade e de
alta mortalidade materna e fetal, este caso é de importante
relevância no tratamento das doenças valvares durante o
período gestacional, bem como a condução nos períodos intra
e pós-operatório.
Descritores:  Procedimentos cirúrgicos cardíacos.
Gravidez. Próteses valvulares cardíacas. Valva mitral,
cirurgia. Valva aórtica, cirurgia.
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INTRODUCTION
In the early 1950s, the first heart surgery reports
performed during pregnancy appeared in Brazil. It was
observed then that maternal mortality was not as high as
that verified in non pregnant women undergoing the same
type of surgical procedure [1].
Although maternal mortality is low, the same is not true
about fetal mortality, which has arose after the introduction
of cardiopulmonary bypass (CBP) as a consequence of
premature obstetric labor and intraoperative fetal death due
to hypoxia [1,2]. On account of the improvement of
knowledge about CPB technique and its fetal
repercussions, several strategies have been described
aiming at reducing fetal morbid-mortality rate [1,2].
The aim of this study is to evaluate fetal and maternal
outcomes of a pregnant woman undergoing a complex heart
surgery procedure.
CASE REPORT
We report a case of a 31-year-old woman, at 20 weeks of
gestation, who underwent mitral valve replacement by
biological prosthesis seven years ago. An echocardiogram
showed a mitral prosthesis dysfunction of a stenosis type
with a mitral valve area [MVA] = 1.0 cm2, moderate to severe
aortic insufficiency, and mitral regurgitation. In addition, there
was a presence of left atrial thrombus and a New York Heart
Association (NYHA) functional class IV heart failure with
frequent episodes of pulmonary edema. Considering this, a
surgical procedure to replace both the biological mitral valve
prosthesis and the aortic valve by biological prosthesis was
performed. Mitral valvuloplasty and a left atrial thrombectomy
were recommended. CBP was performed in the usual fashion,
with modified ultrafiltration and myocardial protection
through both anterograde and retrograde routes, besides
moderate systemic hypothermia at 35ºC.
Length of CPB was 105 minutes. Patient remained in
ICU over 4 days and was discharged within 20 days. ICU
fetal outcome was satisfactory. At 29 weeks and 6 days of
gestation, the patient was admitted after a gestational
diabetes diagnosis was made. Fetal distress was also noted.
The patient underwent an uneventfully C-section with 30
weeks and 5 days of gestation. A live born baby, Small for
his/her Gestational Age, the 1-minute and 5-minute APGAR
score were 5 and 8, respectively, birth weight of 1150 g, and
presenting perinatal asphyxia was born. Patient was
discharged in good health conditions and the baby remains
stable under ventilatory support in a neonatal ICU.
DISCUSSION
The incidence of heart disease in pregnant women varies
from 1 to 4% and the most common cause is rheumatic
mitral disease [3], a substrate of the valvular heart disease
described in the current report. The treatment of choice is
the conservative one and when patients are refractory to it,
the option is surgical intervention, which has similar
indications to those observed in non pregnant women.
Women with valvular heart disease during pregnancy
present with increased pathological events, such as
congestive heart failure, arrhythmias, and the need of
initiating or increasing of cardiac medications doses.
Moreover, an increase in hospitalization rates occurs
during pregnancy [4]. In this case, there has been
refractivity to clinical therapy with several episodes of
acute pulmonary edema. Being the mother’s life at risk an
early surgical therapy was recommended with an increase
risk to the fetus’s life. Repair or replacement of the valve
during pregnancy may be indicated in selected patients
who remain symptomatic in spite of adequate medical
therapy [5].
Some gestational characteristic factors such as relative
hypovolemia, increase of both maternal heart rate and
cardiac output, and anemia can cause cardiocirculatory
unbalance and decompensation in pregnant women with
valve heart disease, thereby requiring interventional or
surgical therapy [1,3].
In the current case report, it was chosen the surgical
therapy with double replacement, because the patient was
found to have a high-risk pregnancy, once she was in the
New York Heart Association (NYHA) functional class IV
and presenting valvular lesions, such as mitral
bioprosthesis stenosis and acute pulmonary edema. This
strengthens the gestational participation of the
abovementioned phenomena and the increase of risk for
maternal mortality as gestation progresses, thereby
requiring surgical therapy.
Although maternal mortality is low, general anesthesia,
thoracotomy, and CPB are risk factors for fetal mortality [2].
Moreover, maternal welfare and gestational aspects, such
as maternal age, New York Heart Association (NYHA)
functional class, kind of surgery (emergency, elective,
planned, reoperation), king of gestation (multiple, with or
without abortion, primipara), and gestational age were
considered as contributing risk factors for fetal morbid-
mortality [3].
In this case, it was performed a double valve replacement
(mitral and aortic valve replacement), which increases the
length of cardiopulmonary bypass as well as the fetal
mortality.  In the present case report, there was no fetal
distress during CPB and the fetus was monitored through
ultrasound. In addition, there was no immediate
postoperative distress, which led to an uneventfully
progression of pregnancy; however, there has occurred a
diabetes decompensation in this patient, which led to a
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premature delivery only one month after the surgical
procedure.
Asphyxia of unknown cause has occurred during
delivery. Thus, the baby needed to remain at the neonatal
ICU under ventilatory support in a progressive recovery,
once the baby was preterm infant and undersized for his/
her gestational age.
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